OncoSil Medical Ltd. announced that Christian Dal Cin of The CFO Solution has been appointed as Chief Financial Officer of OncoSil, succeeding Mr. Karl Pechmann who announced his resignation on 24 May 2023. Christian's extensive experience with listed and private companies includes corporate secretarial, accounting and general management through The CFO Solution and previous roles. The CFO Solution has over 20 years' expertise working with listed life science companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | -44.44% |
23/05 | Oncosil Medical Enters Distribution Agreement with Abdulla Fouad Group for Saudi Arabia | MT |
02/05 | OncoSil Medical Raises AU$5.3 Million under Entitlement Offer | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.44% | 11.1M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.13% | 238B | |
+7.05% | 204B | |
-6.50% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- OSL Stock
- News OncoSil Medical Limited
- OncoSil Medical Limited Announces Appointment of Dal Cin as Chief Financial Officer